EBA
ADAP

Eagle Bay Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Eagle Bay Advisors’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,388
Closed -$15K – 295
2021
Q4 		$15K Sell
3,388
-492
-13% -$2.18K 0.01% 597
2021
Q3 		$20K Buy
+3,880
New +$20K 0.01% 585